全文获取类型
收费全文 | 1892篇 |
免费 | 149篇 |
国内免费 | 11篇 |
专业分类
耳鼻咽喉 | 22篇 |
儿科学 | 66篇 |
妇产科学 | 59篇 |
基础医学 | 186篇 |
口腔科学 | 44篇 |
临床医学 | 226篇 |
内科学 | 475篇 |
皮肤病学 | 32篇 |
神经病学 | 84篇 |
特种医学 | 176篇 |
外科学 | 199篇 |
综合类 | 49篇 |
预防医学 | 131篇 |
眼科学 | 21篇 |
药学 | 91篇 |
肿瘤学 | 191篇 |
出版年
2021年 | 23篇 |
2019年 | 29篇 |
2018年 | 20篇 |
2017年 | 22篇 |
2016年 | 15篇 |
2015年 | 46篇 |
2014年 | 41篇 |
2013年 | 51篇 |
2012年 | 71篇 |
2011年 | 78篇 |
2010年 | 65篇 |
2009年 | 50篇 |
2008年 | 64篇 |
2007年 | 69篇 |
2006年 | 89篇 |
2005年 | 60篇 |
2004年 | 67篇 |
2003年 | 56篇 |
2002年 | 46篇 |
2001年 | 60篇 |
2000年 | 55篇 |
1999年 | 50篇 |
1998年 | 42篇 |
1997年 | 39篇 |
1996年 | 59篇 |
1995年 | 32篇 |
1994年 | 26篇 |
1993年 | 33篇 |
1992年 | 35篇 |
1991年 | 43篇 |
1990年 | 42篇 |
1989年 | 44篇 |
1988年 | 58篇 |
1987年 | 42篇 |
1986年 | 32篇 |
1985年 | 42篇 |
1984年 | 26篇 |
1983年 | 21篇 |
1982年 | 14篇 |
1981年 | 18篇 |
1980年 | 17篇 |
1979年 | 26篇 |
1978年 | 12篇 |
1977年 | 25篇 |
1976年 | 19篇 |
1975年 | 26篇 |
1974年 | 22篇 |
1973年 | 18篇 |
1972年 | 11篇 |
1970年 | 12篇 |
排序方式: 共有2052条查询结果,搜索用时 9 毫秒
21.
22.
Osteosarcomatosis 总被引:10,自引:0,他引:10
Hopper KD; Moser RP Jr; Haseman DB; Sweet DE; Madewell JE; Kransdorf MJ 《Radiology》1990,175(1):233-239
A review of the 690 cases of osteosarcoma in the radiographic file of the Armed Forces Institute of Pathology revealed 29 cases of "osteosarcomatosis" (multiple skeletal sites of osteosarcoma). Fifteen of these patients were 18 years old and under and manifested rapidly appearing, usually symmetric, sclerotic metaphyseal lesions. The remaining 14 patients were more than 18 years old and had fewer, asymmetric sclerotic lesions. In most patients (28 of 29), a radiographically dominant skeletal tumor was seen. Pulmonary metastases occurred in the majority of patients and were detected at the same time as the bone lesions. These 29 patients were studied with regard to demographic data and skeletal distribution and radiographic appearance of their lesions. As a result of the findings, a metastatic origin from a primary dominant osteosarcoma is favored over a multifocal origin as the basis for osteosarcomatosis. Osteosarcomatosis is more commonly encountered in the mature skeleton than has been previously recognized. 相似文献
23.
24.
Race, biology, and health care: reassessing a relationship 总被引:2,自引:0,他引:2
W M Byrd 《Journal of health care for the poor and underserved》1990,1(3):278-296
Recent reports reaffirm huge disparities in the health of blacks compared to other Americans. These disparities persist in part because of the current attempt by health policy makers to frame racially based health differences in non-racial terms. Yet an historical analysis shows that since ancient times, blacks have been the victims of racism in the biomedical sciences; health-system discrimination and deprivation; and later, medical and scientific exploitation. Race- and class-based structuring of the health delivery system has combined with other factors, including physicians' attitudes conditioned by their participation in slavery, and the scientific myth of black biological and intellectual inferiority, to establish a "slave health deficit" that has never been corrected. Until the persistent institutional racism and racial discrimination in health policy, health delivery, and medical educational systems are eradicated, African-Americans will continue to experience poor health outcome. 相似文献
25.
RAJVIR BHALWAR HS SANDHU RC AHUJA GK SINGH RP MISRA 《Medical Journal Armed Forces India》1994,50(3):175-180
A population based hybrid design combining element of cohort and cross-sectional approach was used to develop a simple clinical algorithm to predict individual probability of developing hypertension (systolic BP > 140 mm Hg and/or diastolic BP > 90 mmHg). 3615 soldiers initially normotensive at the time of induction into high altitude, were studied by systematic random sampling. Multiple logistic regression analysis showed a high significant association between hypertension and age, body mass index (BMI), tobacco smoking and alcohol consumption. Using the constant/coefficient values obtained from the logistic model and the receiver operating characteristics (ROC) curve analysis, the following predictive rule was developed – To the age in years, add (BMIx 3.86); also add 5.53 if he is a smoker; and add 19.81 if he consumes alcohol. If the total exceeds 142, the individual is at high risk of developing hypertension. This algorithm carries a sensitivity of 68.2% and specificity of 78.5%.KEY WORDS: Hypertension, High altitude 相似文献
26.
27.
28.
Bladder Cancer and Arsenic Exposure: Differences in the Two Populations Enrolled in A Study in Southwest Taiwan 总被引:6,自引:1,他引:6
Lamm SH Byrd DM Kruse MB Feinleib M Lai SH 《Biomedical and environmental sciences : BES》2003,16(4):355-368
Objective Analyses of bladder cancer mortality in the Black Foot Disease (BFD) endemic area of southwest Taiwan conducted by Morales et al. showed a discontinuity in risk at 400 μg/L arsenic in the drinking water in a stratified analysis and no discontinuity in a continuous analysis. 相似文献
29.
Hydroxyapatite is a biocompatible alloplast with the same chemical composition as bone. It is readily incorporated into host bone, does not undergo appreciable resorption, does not incite a clinically significant foreign body reaction, and resists infection. This article describes forms of hydroxyapatite, procedures for use, and clinical examples. 相似文献
30.
Apoptotic-regulatory and complement-protecting protein expression in chronic lymphocytic leukemia: relationship to in vivo rituximab resistance. 总被引:11,自引:0,他引:11
Rajat Bannerji Shinichi Kitada Ian W Flinn Michael Pearson Donn Young John C Reed John C Byrd 《Journal of clinical oncology》2003,21(8):1466-1471
PURPOSE: Rituximab has clinical activity in patients with chronic lymphocytic leukemia (CLL) and has a variety of proposed mechanisms, including apoptosis, complement-dependent cell lysis (CDC), and antibody-dependent cellular cytotoxicity (ADCC). Here we examine pretreatment biologic features that promote resistance to apoptosis and CDC in CLL patients and correlate it with clinical outcome to rituximab-based therapy. PATIENTS AND METHODS: Pretreatment samples from 21 CLL patients treated on a prospective, single-agent rituximab trial were examined for quantitative expression of apoptotic and CDC regulatory proteins, and the level of expression of these proteins was correlated with clinical outcome. RESULTS: Of the 21 patents for whom samples were available, 10 attained a partial response and 11 failed to respond to rituximab therapy. The mean pretreatment expression of Bcl-2, Mcl-1, XIAP, and the ratio of Bcl-2/Bax were higher but not statistically increased in nonresponding patients versus those responding to treatment. In contrast, the pretreatment Mcl-1/Bax ratio was significantly elevated (0.82 +/- 0.28 v 0.39 +/- 0.29, P <.016) in nonresponding patients compared with patients responding to rituximab therapy. Although pretreatment expression of CD55 and CD59 was not associated with response to rituximab therapy, significantly higher levels of CD59 were observed in the CLL cells that were not cleared from the blood at completion of therapy than the level observed at baseline levels (P =.02). CONCLUSION: These data indicate that baseline expression of the Mcl-1/Bax ratio, but not CD55 and CD59, predict for clinical response to rituximab therapy in CLL patients. Further study of disrupted apoptosis in CLL as a potential mechanism of resistance to rituximab appears warranted. 相似文献